| Vol. 13.16 – 28 April, 2022 |
| |
|
|
| Scientists found that dividing ectodermal cells disassembled ECM attachment formed by integrin-mediated focal adhesions next to mesodermal cells, allowing macrophages to move their nuclei ahead and invade between two immediately adjacent tissues. [Science] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors reported the fabrication of aligned cardiac tissues via bioprinting anisotropic organ building blocks composed of human induced pluripotent stem cell-derived cardiomyocytes. [Advanced Materials] |
|
|
|
| Utilizing a filamin B knockout mouse, researchers showed that the vertebral fusions in spondylocarpotarsal syndrome evolved from intervertebral disc degeneration and ossification of the annulus fibrosus, eventually leading to full trabecular bone formation. [Bone Research] |
|
|
|
| Investigators demonstrated a time-lapse atlas of chondrocyte dedifferentiation to provide molecular details and informative biomarkers associated with clinical chondrocyte evaluation. [Bone Research] |
|
|
|
| Adhesion to many kinds of surfaces, including biological tissues, is important in many fields but has been proved to be extremely challenging. The authors developed a mussel inspired hydrogel to achieve both strong adhesion and trigger-detachment. [Small] |
|
|
|
| Researchers revealed a link between matrix mechanics, migratory phenotype, and bioenergetics and suggested that energetic costs were determined by the ECM and influenced cell motility. [Proceedings of the National Academy of Sciences of the United States of America] |
|
|
|
| The authors developed a tissue engineering approach based on decellularized diaphragmatic muscle and human cells for the in vitro generation of diaphragmatic-like tissues as a proof-of-concept of a new option for the surgical treatment of large diaphragm defects. [npj Regenerative Medicine] |
|
|
|
| Scientists combined the decellularized bovine tendon sheet (DBTS) with ECM from tendon-derived stem cells to fabricate a biomechanically and biochemically functional scaffold (tECM-DBTS), to provide a functional and stem cell ECM-based microenvironment for tendon regeneration. [npj Regenerative Medicine] |
|
|
|
| The authors showed that Wnt-1 inducible signaling pathway protein 2 (WISP-2) may have had relevant roles in modulating the turnover of ECM in the cartilage and that its downregulation may have detrimentally altered the inflammatory environment in osteoarthritis cartilage. [Laboratory Investigation] |
|
|
|
| Histone deacetylase 6 (HDAC6) was required for both the interleukin (IL)-1 induction of matrix metalloproteinase (MMP) expression and pro-inflammatory interleukin expression in chondrocytes, implicating an effect on NF-κB signaling. [Scientific Reports] |
|
|
|
| Researchers used the OrganoPlate to develop a humanized 3D in vitro inflammation-on-a-chip model to recapitulate neutrophil transmigration across the endothelium and subsequent migration through the ECM. [Scientific Reports] |
|
|
|
| The authors developed a technique to shrink-wrap micropatterned islands of corneal endothelial cells in a basement membrane-like layer of ECM that enabled the cells to maintain their cell-cell junctions and cytoskeletal structure while in suspension. [Communications Materials] |
|
|
|
|
| Scientists describe the recent advances that have led to a new understanding of adhesion G protein-coupled receptors function and also discuss new insights into the physiological actions of these receptors as well as their roles in human disease. [Physiological Reviews] |
|
|
|
| The authors survey the distribution, function, and formation of cytoplasmic bridges across the eukaryotic tree of life. They find that cytoplasmic bridges are widespread, and were likely ancestrally present, in almost all lineages of eukaryotes with clonal multicellularity [Current Biology] |
|
|
|
|
| OncoC4, Inc. announced that the US FDA has granted Fast Track designation to ONC-392, the company’s next-gen anti-CTLA-4 monoclonal antibody as a single agent for the treatment of patients with metastatic non-small cell lung carcinoma (NSCLC) who have had disease progression on prior anti-PD-(L)1 therapy. [OncoC4, Inc.] |
|
|
|
|
| May 5 – 8, 2022 Boston, Massachusetts, United States |
|
|
|
|
|
| New York University College of Dentistry – New York, New York, United States |
|
|
|
|
| University of Manchester – Manchester, England, United Kingdom |
|
|
|
| Albert Einstein College of Medicine – New York, New York, United States |
|
|
|
| Novo Nordisk – MÃ¥løv, Denmark |
|
|
|
|